Cambridge-based CN Bio has expanded its contract research services by integrating PhysioMimix computational modelling tools with existing organ-on-chip platforms, creating a comprehensive approach to absorption, distribution, metabolism and excretion (ADME) profiling for pharmaceutical development.
Dutch biotechnology company ProteoNic has announced the commercial launch of its 2G UNic transposon platform, combining established vector technology with proprietary transposon systems to improve cell line productivity and reduce development timelines for complex biologics manufacturing.
EpiCypher has launched CUTANA® Fiber-seq, a multiomic genomics platform that simultaneously captures genomic and epigenomic information through single long-read sequencing assays. The Durham, North Carolina-based company announced the technology on 3 September 2025, marking a significant development in molecular genomics capabilities.
Torrey Pines Scientific has introduced the EchoTherm™ Programmable Digital Stirring Hot Plate Model HS40, designed to deliver precise temperature control and reproducible chemical reactions for clinical and research laboratories.
A new service from Aptamer Group promises to reduce biomarker discovery timelines from years to months, reshaping how pharmaceutical and diagnostic companies approach disease marker identification. The platform combines cutting-edge synthetic biology with advanced proteomics to deliver both validated biomarkers and functional binding tools simultaneously.
Siemens Healthineers has launched a comprehensive expansion of its 3gAllergy diagnostic capabilities, introducing nine new component allergens that deliver unprecedented precision in allergy management. Six of these target peanut allergies – the primary culprit behind fatal food-related anaphylaxis – whilst additional components address house dust mites and wheat sensitivities. This enhancement elevates the IMMULITE 2000 […]
FUJIFILM Biosciences has introduced BalanCD HEK293 Perfusion A Medium, the first commercially available cell culture solution specifically optimised for HEK293 cells in perfusion processes. The medium targets gene therapy applications, enabling continuous production of adeno-associated virus (AAV) and lentivirus (LV) vectors with enhanced consistency and scalability.
LUMICKS has launched Avidion, a next-generation Cell Avidity platform designed to address critical gaps in cell therapy development by measuring how immune cells physically engage with tumour targets.
Vapourtec has launched the Peptide-Builder, a benchtop solid-phase peptide synthesis (SPPS) system designed to streamline peptide production in research and clinical laboratories. The automated platform combines compact design with high-throughput capabilities, addressing space constraints whilst maintaining synthesis performance.
AMS Biotechnology (Amsbio) has unveiled an extensive collection of over 325,000 pre-characterised chemical compounds designed to accelerate drug screening applications across discovery and development programmes.
Prins Hendrikstraat 1
5611HH Eindhoven
The Netherlands
info@clinlabint.com
PanGlobal Media is not responsible for any error or omission that might occur in the electronic display of product or company data.
